002007 华兰生物
已收盘 03-20 15:00:00
资讯
新帖
简况
华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份
证券之星 · 03-18 17:21
华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份
股市必读：华兰生物(002007)股东户数14.9万户，较上期减少1.32%
证券之星 · 03-16
股市必读：华兰生物(002007)股东户数14.9万户，较上期减少1.32%
华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.32%
证券之星 · 03-13
华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.32%
股市必读：华兰生物（002007）3月6日董秘有最新回复
证券之星 · 03-09
股市必读：华兰生物（002007）3月6日董秘有最新回复
华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响
证券之星 · 03-06
华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响
华兰生物：血液制品中的罕见病药物仍适用3%简易征收
证券之星 · 03-06
华兰生物：血液制品中的罕见病药物仍适用3%简易征收
华兰生物(002007.SZ)：帕博利珠单抗注射液获准开展临床试验
智通财经 · 02-25
华兰生物(002007.SZ)：帕博利珠单抗注射液获准开展临床试验
华兰生物：截至2026年2月13日，公司共有15.1万多名投资者
证券之星 · 02-24
华兰生物：截至2026年2月13日，公司共有15.1万多名投资者
华兰生物：截至2026年2月10日，公司共有15.1万多名投资者
证券之星 · 02-11
华兰生物：截至2026年2月10日，公司共有15.1万多名投资者
华兰生物：截至2026年1月30日，公司共有15.3万多名投资者
证券之星 · 02-04
华兰生物：截至2026年1月30日，公司共有15.3万多名投资者
华兰生物：2025年已实现流感疫苗出口至巴基斯坦、多米尼加等国家
证券之星 · 02-04
华兰生物：2025年已实现流感疫苗出口至巴基斯坦、多米尼加等国家
华兰生物（002007）披露收到药物临床试验批准通知书，2月3日股价上涨1.05%
证券之星 · 02-03
华兰生物（002007）披露收到药物临床试验批准通知书，2月3日股价上涨1.05%
华兰生物(002007.SZ)：重组Exendin-4-Fc融合蛋白注射液获准开展临试
智通财经 · 02-03
华兰生物(002007.SZ)：重组Exendin-4-Fc融合蛋白注射液获准开展临试
股市必读：华兰生物（002007）1月23日董秘有最新回复
证券之星 · 01-26
股市必读：华兰生物（002007）1月23日董秘有最新回复
股市必读：华兰生物（002007）1月22日董秘有最新回复
证券之星 · 01-23
股市必读：华兰生物（002007）1月22日董秘有最新回复
华兰生物：截至2026年1月20日共有14.8万多名投资者
证券之星 · 01-22
华兰生物：截至2026年1月20日共有14.8万多名投资者
华兰生物（002007）披露控股子公司收到重组带状疱疹疫苗临床试验批准通知书，1月21日股价下跌0.13%
证券之星 · 01-21
华兰生物（002007）披露控股子公司收到重组带状疱疹疫苗临床试验批准通知书，1月21日股价下跌0.13%
股市必读：华兰生物（002007）1月15日董秘有最新回复
证券之星 · 01-16
股市必读：华兰生物（002007）1月15日董秘有最新回复
华兰生物：截至2026年1月9日共有14.8万多名投资者
证券之星 · 01-15
华兰生物：截至2026年1月9日共有14.8万多名投资者
华兰生物（002007）披露参股公司收到药品注册受理通知书，1月12日股价下跌0.45%
证券之星 · 01-12
华兰生物（002007）披露参股公司收到药品注册受理通知书，1月12日股价下跌0.45%
加载更多
公司概况
公司名称：
华兰生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2004-06-25
主营业务：
华兰生物工程股份有限公司的主营业务是血液制品、疫苗、基因工程产品研发、生产和销售。公司的主要产品是血液制品、疫苗制品、创新药和生物类似药。
发行价格：
15.74
{"stockData":{"symbol":"002007","market":"SZ","secType":"STK","nameCN":"华兰生物","latestPrice":14.81,"timestamp":1773990234000,"preClose":14.96,"halted":0,"volume":11368287,"delay":0,"changeRate":-0.01,"floatShares":1574000000,"shares":1827000000,"eps":0.5191,"marketStatus":"已收盘","change":-0.15,"latestTime":"03-20 15:00:00","open":14.91,"high":15.07,"low":14.8,"amount":169000000,"amplitude":0.018,"askPrice":14.81,"askSize":94,"bidPrice":14.8,"bidSize":1612,"shortable":0,"etf":0,"ttmEps":0.5191,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":14.96,"symbolType":"stock","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":16.46,"lowLimit":13.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1827456666,"isCdr":false,"pbRate":2.4,"roa":"--","peRate":28.530148,"roe":"6.55%","epsLYR":0.5958,"committee":0.20817,"marketValue":27065000000,"turnoverRate":0.0072,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-23。","floatMarketCap":23307000000},"requestUrl":"/m/hq/s/002007","defaultTab":"news","newsList":[{"id":"2620675239","title":"华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2620675239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620675239?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:21","pubTimestamp":1773825667,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司持有华兰基因多少比例的股份？华兰生物回复：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800029977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0196","002007","BK0239","BK0028","BK0197","BK0046","BK0188","BK0077","600201","BK0012"],"gpt_icon":0},{"id":"2619100770","title":"股市必读：华兰生物(002007)股东户数14.9万户，较上期减少1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619100770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619100770?lang=zh_cn&edition=full","pubTime":"2026-03-16 02:35","pubTimestamp":1773599713,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，华兰生物报收于15.26元，上涨0.07%，换手率0.48%，成交量7.61万手，成交额1.16亿元。股本股东变化股东户数变动近日华兰生物披露，截至2026年3月10日公司股东户数为14.9万户，较2月13日减少2000.0户，减幅为1.32%。户均持股数量由上期的1.21万股增加至1.23万股，户均持股市值为18.84万元。董秘最新回复投资者： 请问截止2026年3月10日，公司股东人数多少？董秘： 截至2026年3月10日，公司共有14.9万多名投资者，感谢您对公司的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600000978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0239","BK0028","002007","BK0077","BK0185","BK0046","BK0188"],"gpt_icon":0},{"id":"2619160750","title":"华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619160750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619160750?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:15","pubTimestamp":1773393332,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华兰生物披露，截至2026年3月10日公司股东户数为14.9万户，较2月13日减少2000.0户，减幅为1.32%。在生物制品行业个股中，华兰生物股东户数高于行业平均水平，截至3月10日，生物制品行业平均股东户数为3.45万户。从股价来看，2026年2月13日至2026年3月10日，华兰生物区间涨幅为0.33%，在此期间股东户数减少2000.0户，减幅为1.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300029193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0077","BK0197","BK0239","BK0188","002007","BK0046","BK0028"],"gpt_icon":0},{"id":"2618727693","title":"股市必读：华兰生物（002007）3月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2618727693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618727693?lang=zh_cn&edition=full","pubTime":"2026-03-09 01:19","pubTimestamp":1772990350,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，华兰生物报收于15.28元，上涨1.66%，换手率0.64%，成交量10.0万手，成交额1.52亿元。董秘最新回复投资者： 请问公司增值税征收方式是否从 3% 简易征收调整为 13% 一般征收？本次调整为行业统一政策，预计将对行业产生一定影响。有什么实质手段提质增效董秘： 股价受经营环境、经营业绩及行业发展前景等多重因素综合影响。当日关注点来自交易信息汇总：3月6日主力资金净流入1005.46万元，呈现主力积极介入态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900000579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002007","BK0239","BK0028","BK0185","BK0077","BK0188","BK0197"],"gpt_icon":0},{"id":"2617683282","title":"华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2617683282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617683282?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:36","pubTimestamp":1772786170,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价长期低迷向下，估值是否合理？是否与公司治理不良有关？有什么实质手段提质增效华兰生物回复：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响。公司始终坚持稳健经营，持续提升核心竞争力，以扎实的业绩支撑公司长期价值。未来，公司将进一步提高信息披露质量，保持稳定分红，积极传递公司内在价值，切实维护投资者利益。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600026332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0239","BK0028","002007","BK0077","BK0185","BK0046","BK0188"],"gpt_icon":0},{"id":"2617285683","title":"华兰生物：血液制品中的罕见病药物仍适用3%简易征收","url":"https://stock-news.laohu8.com/highlight/detail?id=2617285683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617285683?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785834,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物03月06日在投资者关系平台上答复投资者关心的问题。本次税率调整预计增加的税收成本是多少？根据国家增值税相关政策，血液制品中的罕见病药物仍适用3%简易征收，其他血液制品业务不再适用3%简易征收。本次调整为行业统一政策，预计将对行业产生一定影响。对此，公司将密切关注政策变化，积极优化供应链与进项税管理，提升合规运营水平，努力降低政策影响，持续为公司和股东创造价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600026052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0239","002007","BK0028","BK0185","BK0197","BK0046"],"gpt_icon":0},{"id":"2614481700","title":"华兰生物(002007.SZ)：帕博利珠单抗注射液获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2614481700","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614481700?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:09","pubTimestamp":1772014146,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰生物 公告，公司参股公司华兰安康生物股份有限公司收到国家药品监督管理局《药物临床试验批准通知书》，帕博利珠单抗注射液获同意按生物类似药开展临床试验。公告显示，帕博利珠单抗是一种靶向程序性死亡受体-1的人源化单克隆抗体。帕博利珠单抗通过阻断PD-1与其配体PD-L1/PD-L2的结合，恢复T细胞的肿瘤杀伤功能，增强人体免疫系统对抗肿瘤的能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0197","002007","BK0185","BK0188","BK0239","BK0046","BK0028"],"gpt_icon":0},{"id":"2613382791","title":"华兰生物：截至2026年2月13日，公司共有15.1万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2613382791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613382791?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:27","pubTimestamp":1771925226,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新一期公司的股东人数是多少？华兰生物回复：截至2026年2月13日，公司共有15.1万多名投资者。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400032713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0028","BK0188","BK0077","BK0185","BK0239","BK0197","BK0046"],"gpt_icon":0},{"id":"2610998720","title":"华兰生物：截至2026年2月10日，公司共有15.1万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2610998720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610998720?lang=zh_cn&edition=full","pubTime":"2026-02-11 17:09","pubTimestamp":1770800950,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年2月10日，公司股东人数多少？华兰生物回复：截至2026年2月10日，公司共有15.1万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100026809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0185","BK0197","BK0239","BK0188","002007","BK0046","BK0028"],"gpt_icon":0},{"id":"2608635861","title":"华兰生物：截至2026年1月30日，公司共有15.3万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2608635861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608635861?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:13","pubTimestamp":1770189208,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年1月31日，公司股东人数多少？华兰生物回复：截至2026年1月30日，公司共有15.3万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400020036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0188","BK0046","002007","BK0077","BK0185","BK0028","BK0239"],"gpt_icon":0},{"id":"2608435893","title":"华兰生物：2025年已实现流感疫苗出口至巴基斯坦、多米尼加等国家","url":"https://stock-news.laohu8.com/highlight/detail?id=2608435893","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608435893?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:13","pubTimestamp":1770189206,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问：据报：美、欧、日韩等地流感爆发，公司流感用药出口情况或WHO申请情况？华兰生物回复：尊敬的投资者您好！公司持续推进流感疫苗国际化布局，2025年已实现流感疫苗出口至巴基斯坦、多米尼加等国家。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400020034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002007","BK0046","BK0077","BK0197","BK0028","BK0185","BK0239"],"gpt_icon":0},{"id":"2608877829","title":"华兰生物（002007）披露收到药物临床试验批准通知书，2月3日股价上涨1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608877829","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608877829?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:18","pubTimestamp":1770128301,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，华兰生物报收于15.45元，较前一交易日上涨1.05%，最新总市值为282.34亿元。该股当日开盘15.37元，最高15.48元，最低15.3元，成交额达1.87亿元，换手率为0.77%。近日，华兰生物工程股份有限公司收到国家药品监督管理局下发的《药物临床试验批准通知书》，同意公司自主研发的重组Exendin-4-Fc融合蛋白注射液在成人肥胖或超重患者中开展临床试验。HL08为新一代GLP-1受体激动剂，具有延长生物半衰期、提升用药便利性与疗效持续性的特点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0185","002007","BK0188","BK0046","BK0077","BK0028","BK0197"],"gpt_icon":0},{"id":"2608826653","title":"华兰生物(002007.SZ)：重组Exendin-4-Fc融合蛋白注射液获准开展临试","url":"https://stock-news.laohu8.com/highlight/detail?id=2608826653","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608826653?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:51","pubTimestamp":1770108703,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰生物(002007.SZ)公告，公司收到国家药品监督管理局下发的《药物临床试验批准通知书》，药物名称为：重组Exendin-4-Fc融合蛋白注射液(简称“HL08”)，该药物原获批开展临床试验的适应症为拟用于改善2型糖尿病患者的血糖控制;本次获批新增适应症为拟用于改善肥胖患者的体重控制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华兰生物(002007.SZ)：重组Exendin-4-Fc融合蛋白注射液获准开展临试","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","002007","BK0046","BK0077","BK0197","BK0028","BK0185","BK0239"],"gpt_icon":0},{"id":"2606263739","title":"股市必读：华兰生物（002007）1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606263739","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606263739?lang=zh_cn&edition=full","pubTime":"2026-01-26 02:27","pubTimestamp":1769365628,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，华兰生物报收于15.61元，上涨1.36%，换手率1.1%，成交量17.3万手，成交额2.69亿元。董秘最新回复投资者： 公司能否年报和中报都10派5，来回馈持有多年的股东们董秘： 您好！公司始终重视股东回报，上市以来已累计分红62.53亿元。当日关注点来自交易信息汇总：1月23日主力资金净流入743.65万元，显示主力对华兰生物短期走势持积极态度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0028","BK0077","002007","BK0188","BK0197","BK0185"],"gpt_icon":0},{"id":"2605041961","title":"股市必读：华兰生物（002007）1月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605041961","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605041961?lang=zh_cn&edition=full","pubTime":"2026-01-23 02:08","pubTimestamp":1769105295,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，华兰生物报收于15.4元，上涨0.59%，换手率0.53%，成交量8.39万手，成交额1.29亿元。董秘： 截至2026年1月20日，公司共有14.8万多名投资者，感谢您对公司的关注！来自公司公告汇总：控股子公司重组带状疱疹疫苗获准开展临床试验，属预防用生物制品1.3类新药。该疫苗为预防用生物制品1.3类新药，适用于预防带状疱疹，不适用于预防原发性水痘。目前国内已有两款带状疱疹疫苗上市，市场需求随老龄化加剧持续增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300001091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0028","BK0077","BK0046","002007","BK0188","BK0197","BK0239"],"gpt_icon":0},{"id":"2605745628","title":"华兰生物：截至2026年1月20日共有14.8万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2605745628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605745628?lang=zh_cn&edition=full","pubTime":"2026-01-22 11:35","pubTimestamp":1769052918,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)01月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年1月20日，公司股东人数多少？华兰生物回复：截至2026年1月20日，公司共有14.8万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200015280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0185","BK0239","BK0028","BK0197","BK0188","002007"],"gpt_icon":0},{"id":"2605376483","title":"华兰生物（002007）披露控股子公司收到重组带状疱疹疫苗临床试验批准通知书，1月21日股价下跌0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605376483","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605376483?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:24","pubTimestamp":1769005462,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，华兰生物报收于15.31元，较前一交易日下跌0.13%，最新总市值为279.78亿元。近日，华兰生物工程股份有限公司控股子公司华兰生物疫苗股份有限公司收到国家药品监督管理局下发的《药物临床试验批准通知书》，其申请的重组带状疱疹疫苗获准开展预防带状疱疹的临床试验。该疫苗为预防用生物制品1.3类新药，适用于预防带状疱疹，不适用于预防原发性水痘。目前国内已有两款带状疱疹疫苗上市，市场需求随老龄化加剧持续增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100040904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0197","BK0077","BK0188","BK0028","BK0185","002007","BK0046","159646"],"gpt_icon":0},{"id":"2603987503","title":"股市必读：华兰生物（002007）1月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603987503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603987503?lang=zh_cn&edition=full","pubTime":"2026-01-16 01:40","pubTimestamp":1768498819,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，华兰生物报收于15.48元，下跌0.9%，换手率0.86%，成交量13.49万手，成交额2.09亿元。董秘最新回复投资者： 2026年1月12号，当前有多少股东呢？董秘： 截至2026年1月9日，公司共有14.8万多名投资者，感谢您对公司的关注！当日关注点来自交易信息汇总：1月15日主力资金净流出2508.01万元，显示主力短期内呈离场态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600000724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0028","BK0185","BK0188","BK0046","BK0239","BK0197","BK0077"],"gpt_icon":0},{"id":"2603257806","title":"华兰生物：截至2026年1月9日共有14.8万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2603257806","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603257806?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:45","pubTimestamp":1768437915,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问：2026年1月12号，当前有多少股东呢？华兰生物回复：截至2026年1月9日，公司共有14.8万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500006525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0188","BK0197","BK0239","BK0185","BK0046","002007"],"gpt_icon":0},{"id":"2602232545","title":"华兰生物（002007）披露参股公司收到药品注册受理通知书，1月12日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602232545","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602232545?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:19","pubTimestamp":1768227557,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，华兰生物报收于15.58元，较前一交易日下跌0.45%，最新总市值为284.72亿元。该股当日开盘15.65元，最高15.66元，最低15.45元，成交额达3.33亿元，换手率为1.36%。近日，华兰生物工程股份有限公司发布公告称，其参股公司华兰安康生物股份有限公司收到国家药品监督管理局签发的阿达木单抗注射液境内生产药品注册上市许可《受理通知书》。本次注册申请受理不影响公司近期业绩，最终获批时间与结果存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0185","002007","BK0188","BK0046","BK0077","BK0028","BK0197"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774050462249,"stockEarnings":[{"period":"1week","weight":-0.0295},{"period":"1month","weight":-0.0327},{"period":"3month","weight":-0.0371},{"period":"6month","weight":-0.0588},{"period":"1year","weight":-0.0397},{"period":"ytd","weight":-0.0212}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"149000人(较上一季度减少1.32%)","perCapita":"10561股","listingDate":"2004-06-25","address":"河南省新乡市红旗区华兰大道甲1号","registeredCapital":"182745万元","survey":" 华兰生物工程股份有限公司的主营业务是血液制品、疫苗、基因工程产品研发、生产和销售。公司的主要产品是血液制品、疫苗制品、创新药和生物类似药。","listedPrice":15.74},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰生物,002007,华兰生物股票,华兰生物股票老虎,华兰生物股票老虎国际,华兰生物行情,华兰生物股票行情,华兰生物股价,华兰生物股市,华兰生物股票价格,华兰生物股票交易,华兰生物股票购买,华兰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}